We have updated our Privacy Policy and Terms of Use for Eurasia Group and its affiliates, including GZERO Media, to clarify the types of data we collect, how we collect it, how we use data and with whom we share data. By using our website you consent to our Terms and Conditions and Privacy Policy, including the transfer of your personal data to the United States from your country of residence, and our use of cookies described in our Cookie Policy.
With its proven success in vaccinations during the global pandemic, messenger ribonucleic acid, or mRNA, technology has hit prime time. The versatile platform is already being used to develop investigational vaccines against other infectious diseases. But its potential doesn’t end there. Over the next decade, this technology could transform medicine.
